Stimulation of Spermatogenesis With Recombinant Human Follicle-Stimulating Hormone (Follitropin Alfa; GONAL-f): Long-Term Treatment in Azoospermic Men With Hypogonadotropic Hypogonadism Editorial Comment

被引：0
|
作者：
Niederberger, Craig
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1964 / 1965
页数：2
相关论文
共 32 条
  • [1] Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f®): long-term treatment in azoospermic men with hypogonadotropic hypogonadism
    Matsumoto, Alvin M.
    Snyder, Peter J.
    Bhasin, Shalender
    Martin, Kathryn
    Weber, Thomas
    Winters, Stephen
    Spratt, Daniel
    Brentzel, Jim
    O'Dea, Louis
    [J]. FERTILITY AND STERILITY, 2009, 92 (03) : 979 - 990
  • [2] Gonal-F - Treatment of infertility in men with hypogonadotropic hypogonadism - Follitropin alfa for injection - Serono
    不详
    [J]. FORMULARY, 2000, 35 (09) : 714 - 714
  • [3] TREATMENT WITH RECOMBINANT FOLLICLE-STIMULATING HORMONE, HUMAN MENOPAUSAL GONADOTROPIN AND HUMAN CHORIONIC GONADOTROPIN FOR HYPOGONADOTROPIC HYPOGONADISM AZOOSPERMIC MEN IN JAPAN.
    Kobori, Y.
    Okada, H.
    Ota, S.
    [J]. FERTILITY AND STERILITY, 2013, 100 (03) : S211 - S211
  • [4] Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism
    Bouloux, P
    Warne, DW
    Loumaye, E
    [J]. FERTILITY AND STERILITY, 2002, 77 (02) : 270 - 273
  • [5] A Combined Analysis of Data to Identify Predictive Factors for Spermatogenesis in Men With Hypogonadotropic Hypogonadism Treated With Recombinant Human Follicle-Stimulating Hormone and Human Chorionic Gonadotropin Editorial Comment
    Niederberger, Craig
    [J]. JOURNAL OF UROLOGY, 2010, 183 (02): : 666 - 666
  • [6] Induction of spermatogenesis by recombinant follicle-stimulating hormone (Puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone
    Bouloux, PMG
    Nieschlag, E
    Burger, HG
    Skakkebaek, NE
    Wu, FCW
    Handelsman, DJ
    Baker, GHW
    Ochsenkuehn, R
    Syska, A
    McLachlan, RI
    Giwercman, A
    Conway, AJ
    Turner, L
    Van Kuijk, JHM
    Voortman, G
    [J]. JOURNAL OF ANDROLOGY, 2003, 24 (04): : 604 - 611
  • [7] Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap® (XM17), Comparability with Gonal-f®, and Performance/Consistency
    Rainer Winstel
    Juergen Wieland
    Beate Gertz
    Arnd Mueller
    Hermann Allgaier
    [J]. Drugs in R&D, 2017, 17 : 305 - 312
  • [8] Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap® (XM17), Comparability with Gonal-f®, and Performance/Consistency
    Winstel, Rainer
    Wieland, Juergen
    Gertz, Beate
    Mueller, Arnd
    Allgaier, Hermann
    [J]. DRUGS IN R&D, 2017, 17 (02) : 305 - 312
  • [9] A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin
    Warne, David W.
    Decosterd, Genevieve
    Okada, Hiroshi
    Yano, Yumiko
    Koide, Nakako
    Howles, Colin M.
    [J]. FERTILITY AND STERILITY, 2009, 92 (02) : 594 - 604
  • [10] Manufacturing of recombinant human follicle-stimulating hormone Ovaleap® (XM17): comparability to Gonal-f®, formulation, and stability
    Weiss, Herman
    Winstel, Rainer
    Allgaier, Hermann
    Wieland, Juergen
    Mueller, Arnd
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 146 - 147
1234